middle.news
Microba Deal Gives Genetic Signatures a Larger Diagnostics Platform
9:25am on Tuesday 22nd of September, 2026 AEST
•
Medical Diagnostics
Read Story
Microba Deal Gives Genetic Signatures a Larger Diagnostics Platform
9:25am on Tuesday 22nd of September, 2026 AEST
Key Points
0.654 new GSS shares for each Microba share
Approximately 469 million new GSS shares to be issued
Microba shareholders to own about 67% of the enlarged group
Combined FY2026 revenue of approximately A$29.6 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Genetic Signatures (ASX:GSS)
OPEN ARTICLE